| Screening genetically modified organisms using multiplex-PCR coupled with oligonucleotide microarray J Xu, H Miao, H Wu, W Huang, R Tang, M Qiu, J Wen, S Zhu, Y Li Biosensors and Bioelectronics 22 (1), 71-77, 2006 | 113 | 2006 |
| Selective gene transfection of individual cells in vitro with plasmonic nanobubbles EY Lukianova-Hleb, AP Samaniego, J Wen, LS Metelitsa, CC Chang, ... Journal of Controlled Release 152 (2), 286-293, 2011 | 89 | 2011 |
| P38 MAPK inhibition enhancing ATO‐induced cytotoxicity against multiple myeloma cells J Wen, HY Cheng, Y Feng, L Rice, S Liu, A Mo, J Huang, Y Zu, DJ Ballon, ... British journal of haematology 140 (2), 169-180, 2008 | 66 | 2008 |
| Aptamer‐Engineered Natural Killer Cells for Cell‐Specific Adaptive Immunotherapy S Yang, J Wen, H Li, L Xu, Y Liu, N Zhao, Z Zeng, J Qi, W Jiang, W Han, ... Small 15 (22), 1900903, 2019 | 64 | 2019 |
| Cancer stem cells: a review of potential clinical applications M Podberezin, J Wen, CCJ Chang Archives of Pathology and Laboratory Medicine 137 (8), 1111-1116, 2013 | 61 | 2013 |
| Integrative analysis of next generation sequencing for small non-coding RNAs and transcriptional regulation in Myelodysplastic Syndromes D Beck, S Ayers, J Wen, MB Brandl, TD Pham, P Webb, CC Chang, ... BMC medical genomics 4, 1-16, 2011 | 59 | 2011 |
| Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition J Wen, Y Feng, W Huang, H Chen, B Liao, L Rice, HA Preti, RT Kamble, ... Leukemia Research 34 (1), 85-92, 2010 | 57 | 2010 |
| p38 Mitogen-activated protein kinase and hematologic malignancies Y Feng, J Wen, CC Chang Archives of pathology & laboratory medicine 133 (11), 1850-1856, 2009 | 57 | 2009 |
| NSMAP: a method for spliced isoforms identification and quantification from RNA-Seq Z Xia, J Wen, CC Chang, X Zhou BMC bioinformatics 12, 1-13, 2011 | 50 | 2011 |
| A unique aptamer-drug conjugate for targeted therapy of multiple myeloma J Wen, W Tao, S Hao, SP Iyer, Y Zu Leukemia 30 (4), 987-991, 2016 | 48 | 2016 |
| Targeting the biophysical properties of the myeloma initiating cell niches: a pharmaceutical synergism analysis using multi-scale agent-based modeling J Su, L Zhang, W Zhang, DS Choi, J Wen, B Jiang, CC Chang, X Zhou PloS one 9 (1), e85059, 2014 | 48 | 2014 |
| Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells Y Feng, J Wen, P Mike, DS Choi, C Eshoa, ZZ Shi, Y Zu, CC Chang Stem cells and development 19 (9), 1289-1296, 2010 | 48 | 2010 |
| Characterization of p38 MAPK isoforms for drug resistance study using systems biology approach H Peng, T Peng, J Wen, DA Engler, RK Matsunami, J Su, L Zhang, ... Bioinformatics 30 (13), 1899-1907, 2014 | 47 | 2014 |
| Monitoring the progression of metastatic breast cancer on nanoporous silica chips J Fan, X Deng, JW Gallagher, H Huang, Y Huang, J Wen, M Ferrari, ... Philosophical Transactions of the Royal Society A: Mathematical, Physical …, 2012 | 38 | 2012 |
| Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing J Wen, W Tao, S Hao, Y Zu Journal of Hematology & Oncology 10, 1-11, 2017 | 36 | 2017 |
| Differentiating between Burkitt lymphoma and CD10+ diffuse large B-cell lymphoma: the role of commonly used flow cytometry cell markers and the application of a multiparameter … P McGowan, N Nelles, J Wimmer, D Williams, J Wen, M Li, A Ewton, ... American journal of clinical pathology 137 (4), 665-670, 2012 | 35 | 2012 |
| Drug inhibition profile prediction for NFκB pathway in multiple myeloma H Peng, J Wen, H Li, J Chang, X Zhou PloS one 6 (3), e14750, 2011 | 32 | 2011 |
| Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades T Sun, S Wang, H Sun, J Wen, G An, J Li Leukemia & lymphoma 59 (1), 49-58, 2018 | 30 | 2018 |
| Utilizing a high-throughput microfluidic platform to study hypoxia-driven mesenchymal-mode cell migration Y Zhang, J Wen, L Zhou, L Qin Integrative biology 7 (6), 672-680, 2015 | 25 | 2015 |
| Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions J Wen, W Tao, I Kuiatse, P Lin, Y Feng, RJ Jones, RZ Orlowski, Y Zu International journal of cancer 136 (5), 991-1002, 2015 | 24 | 2015 |
Xiaobo ZhouProfessor and Fellow of AIMBE, University of Texas Health Science Center HoustonПодтвержден адрес электронной почты в домене uth.tmc.edu
